We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
-12.34%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$30.7B
AUM Growth
-$977M
Cap. Flow
+$3.51B
Cap. Flow %
11.43%
Top 10 Hldgs %
8.45%
Holding
3,415
New
975
Increased
649
Reduced
497
Closed
726

Sector Composition

Rank Sector Weight
1 Industrials 11.74%
2 Financials 10.8%
3 Technology 10.52%
4 Healthcare 9.15%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
3126
PUT
Target
TGT
$77.2B
-121,900
Closed -$25.9M
TGTX icon
3127
TG Therapeutics
TGTX
$8.58B
-581,587
Closed -$5.53M
THRY icon
3128
Thryv Holdings
THRY
$87.5M
-34,821
Closed -$979K
THS
3129
DELISTED
Treehouse Foods
THS
-12,218
Closed -$394K
TLRY icon
3130
CALL
Tilray
TLRY
$649M
-1,000
Closed -$78K
TLT icon
3131
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
-150,000
Closed -$19.8M
TM icon
3132
CALL
Toyota
TM
$229B
-25,000
Closed -$4.51M
TLYS icon
3133
Tilly's
TLYS
$113M
-390,445
Closed -$3.65M
TMCI icon
3134
Treace Medical Concepts
TMCI
$284M
-20,109
Closed -$380K
TME icon
3135
CALL
Tencent Music
TME
$14.2B
-30,000
Closed -$146K
TMO icon
3136
PUT
Thermo Fisher Scientific
TMO
$233B
-14,000
Closed -$8.27M
TNDM icon
3137
Tandem Diabetes Care
TNDM
$1.55B
-102,891
Closed -$12M
TNGX icon
3138
Tango Therapeutics
TNGX
$4.13B
-31,781
Closed -$241K
STLN
3139
Starling Oncology
STLN
$626M
-10,873
Closed -$78K
TPG icon
3140
CALL
TPG
TPG
$8.81B
-155,000
Closed -$4.67M
TPR icon
3141
Tapestry
TPR
$26.3B
-1,615,662
Closed -$52.9M
TRI icon
3142
Thomson Reuters
TRI
$47B
-27,585
Closed -$3.16M
TRIN icon
3143
Trinity Capital Inc
TRIN
$1.76B
-43,830
Closed -$846K
TRN icon
3144
Trinity Industries
TRN
$2.37B
-206,855
Closed -$7.11M
TRNO icon
3145
Terreno Realty
TRNO
$7.51B
-45,502
Closed -$3.37M
TROX icon
3146
Tronox
TROX
$859M
-680,733
Closed -$13.5M
TRV icon
3147
Travelers Companies
TRV
$77.3B
-38,657
Closed -$6.72M
TRVG
3148
trivago
TRVG
$395M
-30,478
Closed -$360K
TS icon
3149
Tenaris
TS
$27B
-252,106
Closed -$7.58M
TTWO icon
3150
PUT
Take-Two Interactive
TTWO
$43.7B
-290,700
Closed -$44.7M

Similar funds

Dmitry Balyasny's Q2 2022 Portfolio in Review

As of Q2 2022, Dmitry Balyasny held 3,415 positions worth $30.7B, down 3.1% from $31.7B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

Dmitry Balyasny deployed $3.51B of net new capital in Q2 2022, opening 975 new positions and adding to 649 existing holdings. Its largest new stake was RTX Corp: 2,351,649 shares worth $226M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was PNC Financial Services, an estimated $134M trimmed.

  • Dmitry Balyasny's largest Q2 2022 buy was RTX Corp: 2,351,649 shares worth $226M.
  • Dmitry Balyasny added most to iShares Russell 2000 ETF in Q2 2022, an estimated $245M increase.
  • Dmitry Balyasny's biggest Q2 2022 reduction was PNC Financial Services, cutting an estimated $134M.
  • Dmitry Balyasny fully exited Honeywell in Q2 2022, selling an estimated $179M.
  • Dmitry Balyasny's ten largest holdings make up 8.5% of its $30.7B portfolio in Q2 2022.
  • Dmitry Balyasny opened 975 new positions and closed 726 in Q2 2022.
  • Dmitry Balyasny's portfolio value fell 3.1% quarter-over-quarter to $30.7B.

Based on Balyasny Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.